Overweight , Obesity
62
16
24
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 62 trials
100.0%
+13.4% vs benchmark
10%
6 trials in Phase 3/4
0%
0 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 17 completed trials
Clinical Trials (62)
Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health Benefits
Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
TRPTI Metabolic and GLP-1 Pharmacodynamic Study
Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia
Retrospective Continuous Glucose Monitor (CGM) Study on Glycemic Response and Body Composition in College Students
Exercise, Chronotype, and Prediabetes
Community Physical Exercise Program in Chronic Disease
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Phase 2 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity
A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese Participants
BfedBwell INSPIRE Pilot
Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers
A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)
Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity